All results are for the primary analyses on healthy young adults in standard AX-CPT and DPX paradigms, unless explicitly stated otherwise. Forest plots were generated to summarize between-study variation (Lewis & Clarke, 2001) in accuracy (Fig. 3) and reaction time (Fig. 4) metrics of proactive versus reactive control.
Delay and trial parameters by behavior/imaging modality
We first ran a set of one-way ANOVAs on all studies in our meta-analysis to understand whether delay length or trial set count differed between studies of different imaging modalities (behavior vs. EEG vs. fMRI). We found that AX-CPT and DPX delay lengths differ between imaging modalities, F(2, 70) = 6.472, p = .003: EEG studies use significantly shorter cue-probe delays (n = 12, mean = 1.86 s) than behavioral studies (n = 46, 3.08 s; EEG vs. BEH t = −3.645, p < .001, Cohen’s d = −.843) or fMRI studies (dp = 15, mean = 4.44 s; EEG vs. fMRI t = −4.146, p < .001, Cohen’s d = −1.496). In addition, cue–probe delay length was negatively correlated with trial set count, F(1, 67) = 7.282, p = .009, R2 = .084, and trial set counts were significantly different by modality, F(2, 66) = 34.77, p < .001, being larger in EEG studies relative to both behavioral (EEG vs. BEH t = 4.803, p < .001, Cohen’s d = 2.391) and fMRI (EEG vs. fMRI t = 5.108, p < .001, Cohen’s d = 2.169) studies. The outcomes of meta-analytic findings reported below should be considered in light of these systematic variations between different modalities, particularly as threats to external validity.
Baseline variation in accuracy and reaction time metrics
We first tested for meaningful between-study variation in both accuracy and reaction time indices of control. In a fixed-effects univariate metaregression, we observed significant variance in the accuracy outcome measure, Q(df = 44) = 300.442, p < .001, z = 11.591. We also observed significant variance in the reaction time outcome measure, Q(df = 43) = 400.614, p < .001, z = 25.260.
In a random-effects univariate metaregression, we observed significant variance in the accuracy outcome measure, Q(df = 44) = 300.442, p < .001, t = 5.355, tau2 = .325, SE = 0.084, I2 = 86.61%, H2 = 7.47. We also observed significant variance in the reaction time outcome measure, Q(df = 43) = 400.614, p < .001, t = 10.213, tau2 = .461, SE = 0.116, I2 = 89.51%, H2 = 9.53.
Differences in AX-CPT versus DPX paradigms
We conducted univariate random-effects meta-regressions to test the effect of stimulus type: AX-CPT letters versus DPX dots as a categorical moderator. In healthy young adults, (AX-CPT dp = 41; DPX dots dp = 4) there was no significant effect of paradigm on accuracy (p = .469) or reaction time (p = .266). In slightly older adults (AX-CPT dp = 5; DPX dp = 5), there was no significant effect of paradigm on accuracy (p = .530). Only two DPX data points (and four AX-CPT data points) in slightly older adults included reaction time data, so we were underpowered to detect potential paradigm-evoked differences in reaction time in slightly older adults (p = .051).
Main effects: Delay knowledge
Univariate random-effects meta-analyses for accuracy and reaction time were conducted with delay knowledge as a categorical moderator (known vs. jittered vs. unknown). Overall, delay knowledge did not account for a significant portion of variance in accuracy (R2 = 8.55%), F(1, 42) = 2.159, p = .128. The difference in accuracy for studies with unknown versus known delays was significant, F(1, 42) = 4.255, p = .045, but accuracy in studies with unknown versus jittered delays did not differ, F(1, 42) = 1.832, p = .183, nor did studies with known versus jittered delays, F(1, 42) = .000, p = .984.
Overall, delay knowledge did account for a significant portion of variance in reaction time (R2 = 19.43%), F(1, 41) = 4.993, p = .011. Reaction time differed significantly for studies with unknown versus known delays, F(1, 41) = 9.811, p = .003, but there was no difference in reaction time for studies with unknown versus jittered delays, F(1, 41) = 1.942, p = .171, nor for studies with known versus jittered delays, F(1, 41) = .697, p = .409. In summary, delay knowledge explained significant variance in RT, with known delay driving relatively increased RT indices of proactive control.
Main effects: Cue–probe delay length and intertrial interval
We conducted univariate random-effects metaregressions for accuracy and reaction time, with cue–probe delay length and intertrial interval (ITI) as continuous moderators. Delay length was not a significant moderator of accuracy, F(1, 41) = .049, p = .827, nor was ITI, F(1, 41) = .108, p = .744. The delay–ITI interaction for accuracy was also not significant, F(1, 41) = .245, p = .623.
Delay length was not a significant moderator of reaction time, F(1, 40) = .205, p = .653, nor was ITI, F(1, 40) = .027, p = .871. The delay–ITI interaction for reaction time was also not significant, F(1, 40) = .375, p = .544. In summary, contrary to our hypothesis, delay length did not explain meaningful variance in accuracy or RT relevant to proactive versus reactive control. In addition, ITI also had no effect on control metrics.
Main effects: Trial set length
We conducted univariate random-effects metaregressions for accuracy and reaction time, with trial set length as a continuous moderator. Trial set length was a significant moderator of accuracy (R2 = 5.71%), F(1, 41) = 4.562, p = .039, such that increased trial set count led to accuracy index measures of greater proactive control.
Trial set length was a significant and robust moderator of reaction time, F(1, 40) = 10.967, p = .002, accounting for 21.89% of variance (R2 = 21.89%), such that increased trial count led to RT index measures of greater proactive control. In summary, both accuracy and RT measures of proactive versus reactive control were altered by trial set length, with increased trial set length associated with greater proactive control.
Interactions: Delay known by delay length and intertrial interval
In a series of univariate mixed-effects metaregressions, we assessed whether there was an interaction between delay knowledge and delay length or ITI in moderating accuracy or reaction time. We found no significant interaction of delay knowledge (known vs. unknown) and delay length on accuracy, F(1, 40) = 1.035, p = .315. The interaction of delay knowledge (known vs. unknown) and ITI also did not have a significant moderating effect on accuracy, F(1, 39) = 1.070, p = .307.
The interaction of delay knowledge (known vs. unknown) and delay length did not significantly moderate reaction time, F(1, 39) = .106, p = .746. However, the interaction of delay knowledge (known vs. unknown) and ITI was a significant moderator of reaction time, F(1, 38) = 5.285, p = .027. Overall, the interaction of delay knowledge and ITI accounted for a significant amount of reaction time variance (R2 = 33.68%), F(1, 38) = 4.054, p = .005. In summary, the interaction of ITI length and delay knowledge was a significant moderator of the RT index of proactive versus reactive control, with longer ITIs associated with less proactive control, but the effect was only present for known delays.
Interactions: Delay known by trial set count
In a set of univariate mixed-effects metaregressions, we assessed whether there was an interaction between delay knowledge (factor) and trial set count (as a continuous variable) in moderating accuracy or reaction time. We observed a significant and robust interaction of delay knowledge and trial count on moderating accuracy, F(1, 37) = 4.350, p = .003; these variables accounted for 38.58% of accuracy variance. Following up this significant interaction, the interaction of known versus unknown delay studies with trial set count was strongly significant, F(1, 37) = 12.373, p = .001. There was no interaction involving jittered versus known studies, F(1, 37) = .292, p = .592, nor jittered versus unknown studies, F(1, 37) = .353, p = .556.
The interaction of delay knowledge and trial set count was a significant and robust moderator of reaction time, F(1, 36) = 5.412, p < .001, accounting for 42.28% of variance. Following up this significant interaction, we found that the interaction of known versus unknown delay studies with trial set count was significant, F(1, 36) = 4.586, p = .039, whereas the interactions with jittered versus known, F(1, 36) = .038, p = .846, and jittered versus unknown, F(1, 36) = .750, p = .392, studies were not significant. In summary, the interaction of delay knowledge and trial set count was a robust and significant predictor of control metrics for accuracy and reaction time, with known delay studies of high trial count associated with the highest rates of proactive control.
Interactions: Trial set count by delay length and intertrial interval
A series of univariate mixed-effects metaregressions were run to understand whether there was an interaction between trial set count and delay length or ITI on accuracy or reaction time. The interaction between trial set count and delay length did not moderate accuracy, F(1, 39) = .000, p = .995, nor did the interaction between trial set count and ITI, F(1, 39) = .046, p = .831.
Trial set count and delay length did not show a significant interaction for reaction time, F(1, 38) = .310, p = .581, nor did trial count and ITI, F(1, 38) = .121, p = .730. In summary, neither trial count nor ITI interacted with trial set count to moderate accuracy or RT control indices.
Subgroup: Mid-delay distractors
Healthy young adult accuracy in standard expectancy paradigms did not differ from that in paradigms with mid-delay distractors (dp = 7), F(1, 69) = .122, p = .728, but reaction time was marginally different, F(1, 61) = 3.548, p = .064. All studies with distractor paradigms were run with fully known delay lengths, so delay knowledge is not included in any analyses for this subgroup. Accuracy was not moderated by delay length, F(1, 5) = .056, p = .823, nor ITI, F(1, 5) = .733, p = .431, nor trial set count, F(1, 5) = .002, p = .964. Reaction time was not moderated by delay length, F(1, 5) = .453, p = .531, nor ITI, F(1, 5) = .731, p = .431, nor trial set count, F(1, 5) = 1.131, p = .3360. In summary, paradigms with mid-delay distractors did not show significant control biases, relative to standard paradigms. Distractor paradigm control metrics were not modified by delay length nor ITI nor trial set count.
Subgroup: Healthy, slightly older adults
Healthy, slightly older adults (mean age >30; k = 5, dp = 10, mean age = 37.8 years, range: 31.6–43.6) differed significantly from healthy young adults (mean age < 30; k = 31, dp = 46, mean age = 22.2 ± 2.14 SD, range: 19.4–26.0) in accuracy, F(1, 69) = 7.392, p = .008, but not reaction time, F(1, 61) = .388, p = .536, indices of control. All studies with slightly older adults were run with fully known delay lengths, so delay knowledge was not included in any analyses for this subgroup. We used univariate metaregressions to assess the effects of delay length, ITI, and trial set count in slightly older adults (dp = 10). Delay length did not moderate accuracy, F(1, 8) = 1.345, p = .280, nor did ITI, F(1, 8) = .444, p = .524. Trial set count conferred a marginally significantly effect on accuracy accounting for 24.80% of variance, F(1, 8) = 4.319, p = .071. Increasing trial set count was associated with a trend toward decreased accuracy index of proactive control, which is the opposite direction from the trial set effects in healthy young adults. This effect of trial set count between younger and slightly older adults was marginally significant, F(1, 47) = 3.246, p = .078. Reaction time was not moderated by delay length, F(1, 4) = .664, p = .461, nor ITI, F(1, 4) = 1.550, p = .281, nor trial set count, F(1, 4) = 4.543, p = .100.
In post hoc analyses, older (elderly) adult accuracy and reaction time was compared with that of slightly older and young adults. Accuracy did not differ between slightly older adults and older (elderly) adults, F(1, 58) = .298, p = .587, whereas reaction time metrics of control did differ between slightly older and older (elderly) adults, F(1, 53) = 7.715, p = .008, with older (elderly) adults showing greater reactive control. As expected, both accuracy, F(1, 58) = 7.334, p = .009, and reaction time, F(1, 53) = 8.773, p = .005, differed between older (elderly) adults and young adults.
In summary, slightly older adults showed accuracy performance that was similar to that in older (elderly) adults and significantly less proactive than that in young adults. Conversely, slightly older adult reaction time metrics were similar to that in younger adults, and more proactive than those shown in older (elderly) adults. Slightly older adults also showed a marginally significant effect of trial set length on accuracy. Interestingly, increasing trial set count tended to decrease proactive control, which was an opposite pattern from that in young adults. This effect was marginally different between groups, where more trials led to a greater effect size differentiation between healthy young and slightly older adult participants.
Subgroup: Schizophrenia
Studies in persons with schizophrenia included four studies sampling young adults with schizophrenia (k = 4, mean age = 22.0 years), six studies sampling slightly older adults with schizophrenia (dp = 6, mean age = 37.7), and one study with unreported sample age. When compared to their age-matched controls, young adults with schizophrenia did not differ in accuracy (dp = 7), F(1, 5) = 1.620, p = .259, nor reaction time (dp = 7), F(1, 5) = 1.786, p = .239, from healthy young adults. In contrast, slightly older adults with schizophrenia showed significantly different (more reactive) accuracy than their age-matched healthy (slightly older) adults (dp = 12), F(1, 10) = 12.744, p = .005. Reaction time metrics did not differ between slightly older adults with schizophrenia and healthy slightly older adults (dp = 7), F(1, 5) = 1.350, p = .298.
All data points with these samples were run with fully known delay lengths, so delay knowledge was not included in any analyses for this subgroup. We used univariate metaregressions to assess the effects of delay length, ITI, and trial set count in participants with schizophrenia. We collapsed across age for moderator analyses due to the small number of studies in each age range. Accuracy was not moderated by delay length, F(1, 9) = .011, p = .920, but ITI showed a marginally significant effect, F(1, 9) = 4.721, p = .058, R2 = 21.39%. Trial set count was a very strong moderator of accuracy, F(1, 7) = 25.969, p = .001, R2 = 100.00%, such that increasing trial set count was associated with increased proactive control. This effect of trial set count on accuracy was similar to that found in healthy young adults, F(1, 46) = 2.233, p = .142. Reaction time was not moderated by delay length, F(1, 6) = .778, p = .412, nor ITI, F(1, 6) = 1.035, p = .348, nor trial set count, F(1, 4) = 2.825, p = .168.
In summary, slightly older adults with schizophrenia showed more reactive accuracy performance compared with healthy, slightly older adults, but there were no differences in performance between young adults with schizophrenia and their healthy young adult controls. Collapsing across age, trial set count was the only moderator to bias performance in schizophrenic patients, enhancing proactive control accuracy indices in a similar manner as in healthy young adults.